Document is current
Any future updates will be listed below
-
Authors
Kohlsdorf, Marina https://orcid.org/0000-0002-7029-3270
Hooley, Cole https://orcid.org/0000-0002-5361-5098
Vázquez, Alejandro L. https://orcid.org/0000-0002-6790-7534
Juras, Mariana M. https://orcid.org/0000-0001-9393-3384
Decker, Grant https://orcid.org/0000-0001-6324-7164
Iskalis, Taylor https://orcid.org/0000-0001-7461-7247
Miller, Kayla https://orcid.org/0000-0003-0928-3804
Tompkins, Quinn https://orcid.org/0009-0008-0357-2019
Buenabad, Nancy G. A. https://orcid.org/0000-0002-9517-5158
Ribeiro, Michela https://orcid.org/0009-0003-8466-6511
Coelho, Acileide C. F. https://orcid.org/0000-0003-3063-4744
Baumann, Ana A. https://orcid.org/0000-0002-4523-0147
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30 CA091842, U19CA291430, 5U01CA275033)
National Institute on Drug Abuse (R61DA062321)
- License Information
-
More Information
Article History
Received: 14 March 2025
Accepted: 10 July 2025
First Online: 4 August 2025
Declarations
:
: Approval and consent to participate Institutional review board (IRB) approval was obtained from Washington University in St. Louis on April 22, 2020 (Protocol #202004215).
: As part of the consent process, participants consented to publish aggregate and anonymous data. Data is available upon reasonable request.
: The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
